| A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement M Eslam, PN Newsome, SK Sarin, QM Anstee, G Targher, ... Journal of hepatology 73 (1), 202-209, 2020 | 3163 | 2020 |
| Thiazolidinediones H Yki-Järvinen New England Journal of Medicine 351 (11), 1106-1118, 2004 | 2840 | 2004 |
| MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease M Eslam, AJ Sanyal, J George, A Sanyal, B Neuschwander-Tetri, ... Gastroenterology 158 (7), 1999-2014. e1, 2020 | 2589 | 2020 |
| EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease European Association for the Study of The Liver, ... Obesity facts 9 (2), 65-90, 2016 | 2538 | 2016 |
| Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men A Seppälä-Lindroos, S Vehkavaara, AM Häkkinen, T Goto, ... The Journal of Clinical Endocrinology & Metabolism 87 (7), 3023-3028, 2002 | 1384 | 2002 |
| Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. M Stumvoll, A Mitrakou, W Pimenta, T Jenssen, H Yki-Järvinen, ... Diabetes care 23 (3), 295-301, 2000 | 1368 | 2000 |
| Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome H Yki-Järvinen The lancet Diabetes & endocrinology 2 (11), 901-910, 2014 | 1248 | 2014 |
| Fatty liver: a novel component of the metabolic syndrome A Kotronen, H Yki-Järvinen Arteriosclerosis, thrombosis, and vascular biology 28 (1), 27-38, 2008 | 1164 | 2008 |
| Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. S Lillioja, AA Young, CL Culter, JL Ivy, WG Abbott, JK Zawadzki, ... The Journal of clinical investigation 80 (2), 415-424, 1987 | 976 | 1987 |
| Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors A Kotronen, M Peltonen, A Hakkarainen, K Sevastianova, R Bergholm, ... Gastroenterology 137 (3), 865-872, 2009 | 905 | 2009 |
| Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 … H Yki-Järvinen, A Dressler, M Ziemen, HOE 901/300s Study Group Diabetes care 23 (8), 1130-1136, 2000 | 859* | 2000 |
| Impaired glucose tolerance as a disorder of insulin action S Lillioja, DM Mott, BV Howard, PH Bennett, H Yki-Järvinen, D Freymond, ... New England Journal of Medicine 318 (19), 1217-1225, 1988 | 815 | 1988 |
| Overproduction of large VLDL particles is driven by increased liver fat content in man M Adiels, MR Taskinen, C Packard, MJ Caslake, A Soro-Paavonen, ... Diabetologia 49, 755-765, 2006 | 788 | 2006 |
| Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes M Tiikkainen, AM Häkkinen, E Korsheninnikova, T Nyman, ... Diabetes 53 (8), 2169-2176, 2004 | 707 | 2004 |
| Glucose toxicity H Yki-Järvinen Endocrine Reviews 13 (3), 415-431, 1992 | 687 | 1992 |
| A desktop guide to type 2 diabetes mellitus. 1999 European Diabetes Policy Group Diabetic Medicine 16 (9), 1999 | 683 | 1999 |
| Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes HU Janka, G Plewe, MC Riddle, C Kliebe-Frisch, MA Schweitzer, ... Diabetes care 28 (2), 254-259, 2005 | 668 | 2005 |
| From the metabolic syndrome to NAFLD or vice versa? E Vanni, E Bugianesi, A Kotronen, S De Minicis, H Yki-Järvinen, ... Digestive and liver Disease 42 (5), 320-330, 2010 | 663 | 2010 |
| Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus: a randomized, controlled trial H Yki-Järvinen, L Ryysy, K Nikkilä, T Tulokas, R Vanamo, M Heikkilä Annals of internal medicine 130 (5), 389-396, 1999 | 654 | 1999 |
| Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study H Yki-Järvinen, R Kauppinen-Mäkelin, M Tiikkainen, M Vähätalo, ... Diabetologia 49, 442-451, 2006 | 597 | 2006 |
